Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis

Clinical trial NCT01066104 · COMPLETED

Trial details

NCT number: NCT01066104
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Rhinosinusitis Nasal Polyps

Start date: 2009-12-01
Primary completion: 2015-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.